Hospira Submits 510(k) Application to FDA for Symbiq Infusion System Modifications

Hospira, Inc. HSP today announced that the company has submitted a 510(k) application with the U.S. Food and Drug Administration for modifications to the Symbiq infusion system. The submission is one of the first developed to align with the recent FDA draft guidance for 510(k) infusion pump clearances.